RPG Investment Advisory’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-30
Closed -$7K 366
2021
Q1
$7K Sell
30
-43
-59% -$8.08K ﹤0.01% 252
2020
Q4
$8K Sell
73
-40
-35% -$4.48K ﹤0.01% 223
2020
Q3
$11K Hold
113
﹤0.01% 184
2020
Q2
$14K Hold
113
﹤0.01% 172
2020
Q1
$10K Hold
113
﹤0.01% 176
2019
Q4
$12K Sell
113
-15
-12% -$1.68K ﹤0.01% 173
2019
Q3
$15K Sell
128
-40
-24% -$6.07K ﹤0.01% 152
2019
Q2
$29K Hold
168
0.01% 122
2019
Q1
$28K Hold
168
0.01% 141
2018
Q4
$16K Sell
168
-202
-55% -$26.5K ﹤0.01% 165
2018
Q3
$64K Sell
370
-30
-8% -$4.33K 0.01% 109
2018
Q2
$56K Hold
400
0.01% 123
2018
Q1
$45K Hold
400
0.01% 162
2017
Q4
$53K Buy
400
+85
+27% +$9.99K 0.01% 145
2017
Q3
$32K Hold
315
0.01% 170
2017
Q2
$32K Buy
+315
New +$33.9K 0.01% 150

Other funds holding GWPH

RPG Investment Advisory's GWPH Position: Q2 2021 in Review

RPG Investment Advisory sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 30 shares — an estimated $7K sold.

RPG Investment Advisory first reported a position in GWPH in Q2 2017 and held it in 16 quarters. The position peaked at $64K in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • RPG Investment Advisory reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • RPG Investment Advisory sold 30 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7K.
  • RPG Investment Advisory first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 16 quarters.
  • RPG Investment Advisory's GW Pharmaceuticals Plc American Depositary Shares position peaked at $64K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on RPG Investment Advisory's 13F filing for Q2 2021, filed 3 Aug 2021.